Responding to the U.S. Department of Health and Human Services final rule on short-term, limited-duration insurance plans, the Cystic Fibrosis Foundation joined 26 other nonpartisan patient and consumer groups to voice concern that these plans will split the market and jeopardize access to affordable, adequate health care for people living with pre-existing conditions.
- About the CF Foundation
- Public Policy
- Our Research Approach
- Clinical Trials
- Our Advocacy Work
- Cystic Fibrosis Foundation Therapeutics (CFFT)
- Genetic Therapies
- Drug Pipeline
- CFTR Modulators
- Get Involved
- Care Centers
- Family Planning & Parenting
- North American CF Conference
- Traveling with CF
- Coronavirus (COVID-19)
- Intro to CF
- Patient Assistance
- Adult Care
- Fertility and Reproductive Health
- Infection Prevention and Control
- Mental Health
- Researcher Resources
- Treatment Plan
- CF-Related Complications
- Clinical Care Guidelines
- Clinician Resources
- Diversity, Equity, and Inclusion
- Lung Transplantation
- Patient Registry
- (-) Health Care Reform
The Cystic Fibrosis Foundation has joined 11 other patient groups in filing an amicus brief to challenge the short-term, limited-duration health insurance rule, which threatens access to adequate, affordable coverage for people with cystic fibrosis.
The organizations called on Congress to take a bipartisan approach to reform.
The Cystic Fibrosis Foundation joins 15 patient and provider groups to oppose this bill, which would negatively impact patients' access to adequate and affordable health coverage and care.
A nonpartisan group of 29 patient, provider, and consumer groups praised the Senate Health, Education, Labor, and Pensions (HELP) Committee for crafting bipartisan legislation that will help stabilize the individual insurance markets.
As the Senate considers adding repeal of the Affordable Care Act's (ACA) individual mandate to its tax reform package, a group of 16 nonpartisan patient and consumer groups issued a statement on last week's Congressional Budget Office (CBO) report.
Un diagnóstico de fibrosis quística no debe descalificar a una persona para recibir atención que pueda salvarle la vida.
Patient and provider groups urge the Senate to work together in a bipartisan fashion to ensure that Americans have access to affordable health care.
Rushed CBO Score Fails to Show Graham-Cassidy's Devastating Impact on Patients
Patient and provider groups urge safeguard for the health and lives of millions of Americans with a bipartisan approach to reform.